Skip to main content
SpringerLink
Log in

Nicht mehr nur für schwere Fälle zugelassen

Infliximab bei Morbus Crohn

  • Pharmaforum
  • Published:
MMW - Fortschritte der Medizin Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nicht mehr nur für schwere Fälle zugelassen. MMW - Fortschritte der Medizin 153, 60–61 (2011). https://doi.org/10.1007/BF03368825

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03368825

Search

Navigation